Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct;32(10):338-345.
doi: 10.1007/s12471-024-01896-2. Epub 2024 Sep 10.

2023 European Society of Cardiology guidelines for the management of acute coronary syndromes : Statement of endorsement by the NVVC

Bastiaan Zwart  1 , Bimmer E P M Claessen  2 , Peter Damman  3 , Pier Woudstra  4 , Maarten A Vink  5 , J Willem Balder  6 , Michael G Dickinson  6 , Erik A Badings  7 , Yolande Appelman  8 , Arnoud W J van 't Hof  9   10 , Jurriën M Ten Berg  9   11 , Fatih Arslan  12
Affiliations
Review

2023 European Society of Cardiology guidelines for the management of acute coronary syndromes : Statement of endorsement by the NVVC

Bastiaan Zwart et al. Neth Heart J. 2024 Oct.

Abstract

This review discusses the new recommendations in the 2023 European Society of Cardiology guidelines on the management of acute coronary syndrome and provides a perspective on topics specific to clinical practice in the Netherlands, including pre-treatment, antiplatelet agent strategies, the use of risk scores and logistical considerations with regard to the timing of coronary angiography.

Keywords: Acute coronary syndrome; Antiplatelet therapy; Guidelines; Percutaneous coronary intervention.

PubMed Disclaimer

Conflict of interest statement

B. Zwart has received speakers/consultancy fees from Bayer and AstraZeneca. B.E.P.M. Claessen has received honoraria from Abbott Vascular, Abiomed, Amgen, B. Braun, Boston Scientific, Philips and Sanofi for consultancy, speaking engagements and/or advisory board engagements. P. Damman has received research grants from Abbott, Philips, AstraZeneca and consultancy fees from Philips. P. Woudstra has received speakers fees from Philips and consultancy fees from Sanofi. Y. Appelman has received research grants from the Dutch Heart Foundation. In the past 36 months, A.W.J. van ’t Hof has received unrestricted grants from Abbott Vascular, Boehringer Ingelheim, Sanofi and consultancy fees from Celecor Therapeutics. J.M. ten Berg has received institutional research grants ZonMw, Daiichi Sankyo and advisor fees from CeleCor. M.A. Vink, J.W. Balder, M.G. Dickinson, E.A. Badings, and F. Arslan declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Invasive strategies according to symptom onset and stratified for acute coronary syndrome (ACS) diagnosis. NSTE-ACS non-ST-elevation acute coronary syndrome, pPCI primary percutaneous coronary intervention, EMS emergency medical service, ICA invasive coronary angiography, ESC European Society of Cardiology, GRACE Global Registry of Acute Coronary Events
See this image and copyright information in PMC

References

    1. Byrne RA, Rossello X, Coughlan JJ, et al. ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;2023:3720–826. - DOI - PubMed
    1. Montalescot G, van ’t Hof AW, Lapostolle F, et al. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014;371:1016–27. - DOI - PubMed
    1. Gewehr DM, et al. Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2023;102:200–11. - DOI - PubMed
    1. Yusuf S, Mehta SR, Chrolavicius S, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS‑6 randomized trial. JAMA. 2006;295:1519–30. - DOI - PubMed
    1. Schüpke S, Neumann F‑J, Menichelli M, et al. Ticagrelor or prasugrel in patients with acute coronary syndromes. N Engl J Med. 2019;381:1524–34. - DOI - PubMed

LinkOut - more resources